Mizuho has revised its price target for Cabot (CBT, Financial), reducing it from $100 to $95 while maintaining an "Outperform" rating on the stock. This adjustment comes as part of a broader update in the chemical, agriculture, and packaging sectors, reflecting recent declines in market multiples. The firm has only slightly adjusted its forward estimates, as it does not anticipate a recession in the near term.
The decrease in oil prices is expected to impact many basic chemical companies by reducing their gas-linked cost advantages. Additionally, Mizuho cautions that there may be near-term volatility due to prior pre-buying activities in the automotive and electronics sectors, which could lead to a correction or "give-back."
Wall Street Analysts Forecast
Based on the one-year price targets offered by 4 analysts, the average target price for Cabot Corp (CBT, Financial) is $93.75 with a high estimate of $100.00 and a low estimate of $83.00. The average target implies an upside of 19.29% from the current price of $78.59. More detailed estimate data can be found on the Cabot Corp (CBT) Forecast page.
Based on the consensus recommendation from 5 brokerage firms, Cabot Corp's (CBT, Financial) average brokerage recommendation is currently 2.6, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Cabot Corp (CBT, Financial) in one year is $80.26, suggesting a upside of 2.12% from the current price of $78.59. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Cabot Corp (CBT) Summary page.
